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chocardiography in Percutaneous
alve Therapy
asneem Z. Naqvi, MD
os Angeles, California
chocardiography has played a critical role in valve reconstructive surgery and more recently in develop-
ents in percutaneous techniques for mitral valve repair and aortic valve implantation. A combination of
ransthoracic echocardiography and transesophageal echocardiography (TEE) provide diagnostic and
creening data pre-procedure, intraprocedural guidance, and assessment of valve function and left ven-
ricular reverse remodeling post-percutaneous valve procedures. The role of intracardiac echocardiogra-
hy and live 3-dimensional TEE in percutaneous valve interventions is evolving. This review summarizes
he role of echocardiography during percutaneous device-based valve procedures. (J Am Coll Cardiol
mg 2009;2:1226–37) © 2009 by the American College of Cardiology Foundation(
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Miroliferation of percutaneous technology for
reatment of structural heart disease has led to
demand for online imaging with high spatial
nd temporal resolution and has placed echo-
ardiography in the forefront as a diagnostic
nd therapeutic imaging modality. Recent de-
elopments in successful percutaneous aortic
alve implantation (1,2), pulmonic valve im-
lantation (3), coronary sinus stent placement
or tightening of mitral annulus (4), as well as
ercutaneous edge-to-edge repair of the mitral
alve (MV) (5) in patients with mitral regurgi-
ation (MR) promise a proliferation of percu-
aneous catheter-based techniques for treat-
ent of valvular heart disease (6). This therapy
as a role especially in patients who are poor
urgical candidates due to advanced age, poor
ardiac function, or multiple comorbidities.
This paper focuses on the role of echocardiog-
aphy during recently developed percutaneous
V repair and aortic and pulmonic valve implan-
ation procedures. Three-dimensional (3D) echo-
ardiography and intracardiac echocardiography
rom the Echocardiography Laboratory, University of Southern
alifornia. Dr. Naqvi is a consultant for Edwards Lifesciences andanuscript received July 28, 2009; revised manuscript received AugustICE) during established procedures such as bal-
oon mitral valvuloplasty as well as their evolving
ole in recently introduced percutaneous valve
nterventions are briefly discussed.
Although fluoroscopy and contrast cinean-
iography have been used successfully for in-
erventions within the coronary arteries, poor
oft-tissue contrast resolution limits their abil-
ty to visualize intracardiac anatomy that is
ecessary for percutaneous valve procedures,
emanding alternative imaging modalities for
rocedural guidance. Fluoroscopy and angiog-
aphy can provide reliable guidance during
ercutaneous aortic valve implantation and cor-
nary sinus stent placement; however, most
enters also use transesophageal echocardiog-
aphy (TEE) for aortic valve implantation.
ercutaneous repair of complex structures such
s the MV requires a clear delineation of
ntracardiac anatomy in multiple dimensions to
acilitate catheter manipulation relative to car-
iac chambers and valves, to guide the device to
he desired target site on the valve, and to
fornia, Keck School of Medicine, Los Angeles,
cardia Corporation.17, 2009, accepted August 21, 2009.
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1227valuate valve anatomy, valve gradients, and regur-
itation after device deployment and is heavily
ependent on TEE guidance during repair. Al-
hough other imaging modalities such as magnetic
esonance imaging (7) are undergoing rapid evolu-
ion, and data are emerging on its potential role as
nline imaging, at present, echocardiography is the
ost readily available, portable, online imaging
uide during percutaneous interventions. Please
efer to the Online Appendix for an overview of the
chocardiographic imaging modalities.
chocardiography in balloonmitral valvuloplasty. Echo-
ardiography, both transthoracic echocardiography
TTE) and TEE, has an established role in MV
ercutaneous balloon valvuloplasty (8,9). TTE can be
sed as a stand-alone imaging modality with mini-
um use of fluoroscopy during mitral valvuloplasty
10). TEE is superior to TTE in evaluation of the left
trial (LA) appendage; guidance for transseptal punc-
ure; evaluation of MV leaflets, commissures, and
hordae; and assessment of residual atrial septal defect.
EE should be used for exclusion of LA thrombus
nd/or with an inexperienced interventionalist. Live
D TEE can provide excellent patient selection and
uidance by providing surgical views of the LA ap-
endage, LA, interatrial septum, MV, and chords and
rovides a MV model depicting leaflet and annular
eometry, leaflet angles, and surface area (Online Fig.
1, Fig. 1, Online Videos 1A, 1B, and 2). Three-
imensional TTE and TEE provide more accurate
ssessment of MV area (Online Video 2) than the
lanimetered MV area derived from 2D images,
hereby the ultrasound beam may not transect the
alve in the correct plane, or by the pressure half-time
oppler method, which is unreliable in the immediate
ost-valvuloplasty phase (11). During MV balloon
alvuloplasty, 3D TEE can evaluate leaflet tear and its
xtent better than TTE, 2D TEE, or ICE (12). ICE
as been used successfully in conjunction with TTE
uring percutaneous mitral valvuloplasty (13); how-
ver, it does not provide multiplanar assessment of
he MV.
chocardiography in paravalvular leak repair. Para-
alvular (PV) regurgitation is seen with mechanical
nd bioprosthetic valves. Interrogation in multiple
ngles including off-axis views is required to deter-
ine the location and severity of the regurgitation.
V regurgitation (or leak) is characterized by
oppler flow outside the sewing ring of the valve,
ften in an eccentric direction. TTE may be ade-
uate for most of the qualitative and quantitative
nformation needed to evaluate aortic PV leaks.
EE complements TTE in technically difficult etudies and in evaluating posterior aortic PV leaks.
ecause of artifacts and reverberations, prosthetic
V PV regurgitation, however, may be missed on
TE, and TEE is required for diagnosis, location,
nd assessment of severity. The proportion of the
ircumference of the sewing ring occupied by the jet
ives an approximate guide to severity. MR jet
idth at origin of 1 to 2 mm, 3 to 6 mm, and 6
m, respectively, defines mild, moderate, and large
V leak (14). A combination of semiquantitative
nd quantitative parameters similar to those used
or native valve regurgitation may be used although
ccentric jets may make quantitation difficult.
hree-dimensional color Doppler may improve
uantitation of PV regurgitation. TEE helps eval-
ate contraindications to percutaneous closure of
V leaks, such as mechanical instability of the
rosthetic valve, intracardiac thrombus, and endo-
arditis (15). Real-time 3D TEE is far superior to
D TEE in evaluation of location and
xtent of PV leak (Fig. 2, Online Videos
A, 3B, and 4). TEE plays a critical role in
he percutaneous closure of PV leaks by
roviding guidance on location of trans-
eptal puncture, particularly in patients
ith calcified interatrial septum not un-
ommon with multiple prior valve surger-
es (Figs. 3A and 3B), facilitating place-
ent of the guidewires across the PV
efect (Figs. 3C and 3D), providing guid-
nce on catheter and guide manipulation
o approach the defect perpendicularly,
onfirming adequate seating of the device
cross the defect before deployment, veri-
ying normal prosthetic valve leaflet mo-
ion (Online Video 5A), assessing severity of resid-
al PV regurgitation (Figs. 3F to 3I), evaluating
esidual atrial septal defect after device deployment,
nd detecting procedural complications promptly,
uch as development of thrombus on catheters and
evelopment of pericardial effusion. Using more
han 1 Amplatzer septal occluder device (atrial
eptal defect closure device used off-label for PV
losure) potentially increases the risk of device dis-
odgement with embolization, and lead to interference
ith prosthetic leaflet motion (Online Video 5A) and
isruption of the prosthetic valve. Isolated reports on
se of 3D TEE during closure of PV leak exist (16).
lthough the incremental value of 3D over 2D TEE
uring device closure of PV leak is not established, 3D
EE may allow procedure planning, including proce-
ure feasibility by better assessment of location and
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1228acilitating catheter manipulation, device sizing and
ositioning.
chocardiography in MV repair. TTE provides accu-
ate quantification of MR severity and is able to
etermine etiology of MR as degenerative, ischemic,
r functional. Quantitative assessment of MR by vena
ontracta (width of MR jet at its origin) and measure-
ent of effective regurgitant orifice area and regurgi-
ant volume is now the gold standard for MR quan-
itation (17) (Online Fig. E2) and has been used for
he first time in a multicenter setting in Phase I and
hase II EVEREST (Endovascular Valve Edge-to-
dge REpair STudy) trials (6). TTE often provides
Figure 1. 3D TEE of the MV in Mitral Stenosis
Three-dimensional (3D) volumetric transesophageal echocardiograp
left ventricular (LV) side in a patient with mitral stenosis in A and th
dataset in B. Mitral annular shape, circumference, mitral leaﬂet surfa
line in B is the mitral coaptation line. Also see Online Videos 1A, 1B
lateral commissure; P  posterior; PM  posteromedial commissure
Figure 2. 2D and 3D TEE in PV Leak
Mid-esophageal 2D TEE view at 0° showing paravalvular (PV) leak lo
St. Jude’s mitral valve disks in the closed position are shown by wh
disks in the open position from the atrial aspect. A PV hole is seen
made percutaneous repair nonfeasible. Also see Online Videos 3A, 3
in Figure 1.imited information on valve reparability. Three-
imensional TTE may improve MV assessment al-
hough resolution of 3D TTE remains an important
imitation (Online Fig. E3). At present, percutaneous
V repair technique by the edge-to-edge technique
ims to repair MR originating from the A2 and P2
callops of MV rather than commissures or posteriorly
r anteriorly located MV scallops. TEE evaluates
ocation of diseased mitral scallop/s by using 2D and
olor Doppler in multiple imaging planes (Online Fig.
4), by location of flow convergence (Online Figs. E4
o E7), and by assessment of site of origin of MR jet.
R jet origin in the short-axis view is critical to
TEE) view showing mitral valve (MV) oriﬁce visualized from the
orresponding model reconstructed from 3-dimensional (3D) image
area, and aorto-mitral angle are displayed in B. Curved yellow
d 2. A  anterior; Ao  aortic root; Ant  anterior; AL  antero-
st  posterior.
d anteromedially between St. Jude’s aortic and mitral prostheses.
arrows in A. B is the 3D TEE view showing St. Jude’s mitral valve
he 10 o’clock position (white arrow). The location of the PV leak
nd 4. LA  left atrium; RA  right atrium; other abbreviations ashy (
e c
ce
, ancate
ite
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1229Figure 3. TEE During Percutaneous Closure of PV Leak
A to D show PV leaks by white arrows in a 72-year-old female with 4 prior MV surgeries. Paravalvular leak is shown by white arrows.
Large leak is shown at baseline (A), moderate leak after ﬁrst device deployment (B), mild leak after balloon (*) dilation lateral to the ﬁrst
device (C), and after 2 Amplatzer devices (D). E to H show detection of potential complications with TEE during procedure, shown by
arrows. E shows direction of Brockenbrough needle towards the aortic root, F shows atrial tissue attached to the sheath (withdrawn sub-
sequently with the sheath), G shows passage of wire across the St. Jude’s mitral valve (black arrow), and H shows resulting severe MR
(white arrow). Also see Online Videos 5A and 5B. Ao  aorta; other abbreviations as in Figures 1 and 2.Figure 4. TEE During Initial Stages of Percutaneous MV Repair by Evalve Clip
Mid-esophageal transesophageal views used for guided transseptal puncture during percutaneous edge to edge MV repair. (A) Short-axis view
at the base (showing the anterior–posterior portion of the interatrial septum with tenting (white arrow) at the junction of septum primum
with septum secundum or the edge of the fossa. (B) Bicaval view showing the superior–inferior portion of the interatrial septum. (C) Bicaval
view with tenting at the junction of ostium primum with ostium secundum (white arrow). (D) Mid-esophageal 4-chamber view (for assessing
height of the tenting site above the MV plane) to allow perpendicular approach of the guide and device catheter towards the MV. Also see
Online Videos 6A, 6B, and 6C. IVC  inferior vena cava; SVC  superior vena cava; other abbreviations as in Figure 2.
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1230D
A
D
B C
E F
Figure 5. TEE During Early Stages of Percutaneous MV Repair by Evalve Clip
TEE views at the mid-esophageal level used to guide early stages of Evalve edge-to-edge repair. Transseptal puncture at the superopos-
terior interatrial septum is shown in the mid-esophageal short-axis view at the base of the heart in A and 4-chamber view in B (white
arrowhead). Note the needle tip in the LA in C (white arrowhead), 22-F guide delivery sheath in the LA in D (white arrowhead) and tip
of the device delivery guide and of the therapy catheter in E and F (white arrowheads). Also see Online Videos 6A, 6B, and 6C. Ao 
aorta; other abbreviations as in Figures 1 and 2.A B
C D
Figure 6. TEE During Mid-Stages of Percutaneous MV Repair by Evalve Clip
TEE views at the mid-esophageal level used to guide middle stages of Evalve edge-to-edge repair. 2-chamber (A) and 3-chamber views
(B) are used to navigate the tip of the device (arrowheads) toward the middle of the MV in the mediolateral (A) and anteroposterior
plane (B). White arrows in A and B point to the MV leaﬂets. Device tip is shown in the middle of MR jet in C and D by white arrow-
heads. Also see Online Videos 6A, 6B, and 6C. Abbreviations as in Figures 1 and 2.
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1231valuate location and severity of pathology and com-
lements information obtained by long-axis views
Online Fig. E8).
The first approach to percutaneous MV repair is
he edge-to-edge technique, which creates a double
V orifice replicating the surgical intervention
ioneered by Alfieri et al. (18). Preliminary clinical
esults obtained in over 100 patients from percuta-
eous edge to edge repair using a clip (Evalve, Inc.,
enlo Park, California) in Phase I (6) and II (19)
tudies suggest that in expert hands, the success rate
f the technique is high (80% to 90%), and the
egree of MR can be reduced to mild in two-thirds
f cases. The risk is low in experienced centers. In
atients in whom the procedure was successful,
wo-thirds of the cases remained event-free after 3
ears. Besides assessment of involved scallops,
creening by echocardiography involves measure-
ent of coaptation depth and coaptation length in
schemic MR (Online Fig. E8) and of flail gap
Online Fig. E9) and flail width (Online Fig. E10)
n degenerative MR.
In the catheterization laboratory, TEE is the
A
C
Figure 7. TEE During Mid- to Late Stages of Percutaneous MV R
TEE views at the mid-esophageal and deep transgastric level used t
leaﬂet is on the right and posterior leaﬂet on the left. Open clip is
rugated surface of the grippers and the open Dacron arms are show
is shown in B. Grippers are shown folded upward and the Dacron a
anterior leaﬂets well within the grippers and the closed Dacron arm
posterior leaﬂets after release of the clip from the device assembly.
abbreviations as in Figures 1 and 2.rimary imaging modality used for procedural guid- dnce of MV repair using the Evalve clip. TEE is
ble to visualize all components of the clip delivery
ystem (Figs. 4 to 9, Online Videos 6A, 6B, and
C). TEE guides puncture of the posterior and
uperior portion of the interatrial septum, thereby
llowing perpendicular alignment of device in the
lane of the posteriorly located MV (Fig. 4). By
isualization of guide and device catheter tips, TEE
elps steer these devices in the appropriate direction
nd ensures minimal device–endocardial contact.
EE guides advancement of the therapy catheter
owards the center of pathology by placing it within
he center of maximum MR jet. Steering of the
evice assembly is performed in the mediolateral
nd anteroposterior planes using 2- and 3-chamber
iews, respectively (Fig. 6). The actual procedure of
pening the clip in the LA, its advancement into
he LV, its correct alignment so the device arms are
t right angles to the MV coaptation, and actual
eaflet capture are all guided by TEE (Online
ideos 6A, 6B, and 6C). TEE directs the decision
o release the clip in case of suboptimal MV leaflet
apture or whether the procedure should be aban-
B
D
ir by Evalve Clip
ide middle to later stages of Evalve edge-to-edge repair. Anterior
wn in the LA above the MV leaﬂets (white arrows) in A. The cor-
white asterisks). Open clip advanced into the LV through the MV
opened horizontally (white asterisks). C shows that posterior and
the clip. D shows the clip along with the captured anterior and
see Online Videos 6A, 6B, and 6C. AV  aortic valve; otherepa
o gu
sho
n (
rms
s of
Alsooned in cases of minimal MR reduction once
l
r
m
M
i
i
fl
r
lops
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1232eaflets are grasped. TEE confirms an adequate
esult by reduction in the MR grade to less than
oderate and by visualizing anterior and posterior
V leaflet anatomy. TEE is able to determine the
A
Figure 8. TEE During Late Stages of Percutaneous MV Repair by
A transgastric short-axis view at the mitral valve (MV) level showing cli
leaﬂets (white horizontal arrow) in A. B shows a 90° rotation of the cl
arrow) before the clip is pulled back for mitral leaﬂet capture. MV scal
Figure 9. TEE Doppler Evaluation During Evalve Clip Deploymen
Mid-esophageal views showing 2D and Doppler evaluation performed
the need for a second clip is made. Multiple views and angulation are
3-chamber view with color Doppler. No color Doppler evidence of resi
continuous wave Doppler of mitral inﬂow to evaluate peak and mean
Doppler signals obtained from the left inferior pulmonary vein showin
tolic (S) dominant ﬂow pattern in the same pulmonary vein post-clip deplommediate effect of MR reduction on cardiac phys-
ology, including MV gradients, pulmonary venous
ow pattern, right ventricular systolic pressure, and
esidual MV area before the clip is finally deployed
alve Clip
ms parallel to the plane of coaptation of anterior and posterior MV
ms so these are perpendicular to MV coaptation (white vertical
are labeled in diastole in A. Also see Online Videos 6A, 6B, and 6C.
r the clip is released before decision on the adequacy of capture or
d to ensure that eccentric jets are not missed. A shows apical
MR after clip deployment (white arrow) is shown in A. B shows
gradients to ensure lack of mitral stenosis. C and D are pulsed wave
stolic ﬂow reversal (white arrows) pre-clip deployment in C and sys-B
Ev
p ar
ip art
afte
use
dual
MV
g syyment in D. Also see Online Videos 6A, 6B, and 6C.
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1233Fig. 9). TEE determines the need for a second clip
y assessing the severity of residual MR and guides
lacement of the guidewire and therapy catheter in
he correct orifice of a double orifice MV (Fig. 10,
nline Videos 7A and 7B). TEE confirms the final
R grade and size of residual atrial septal defect
efore the completion of the procedure. TEE al-
ows immediate detection of procedural complica-
ions such as development of thrombus on cathe-
ers, pericardial effusion, and tangling of device with
hordae. Finally, echocardiography evaluates MR
everity during follow-up, device stability and effect
n LV size and function, and pulmonary artery
ressure. Isolated case examples on the use of live
D TEE during MV repair are beginning to
merge (16). The incremental value of 3D TEE in
his procedure has not been examined, but it may
uide perpendicular alignment of therapy catheter
o the MR jet in patients with markedly dilated LA
nd may significantly shorten procedure time by
roviding surgical-type views of mitral apparatus.
The second possible approach of mitral annulo-
lasty, which is achieved by introducing a constraining
evice in the coronary sinus located in the vicinity of
he mitral annulus can be accomplished by fluoroscopy
nd coronary sinus angiography. Preliminary efficacy
ata suggest some reduction in the degree of MR in
Figure 10. TEE Evaluation of Residual MR After Evalve Clip Dep
Mid-esophageal TEE views in the mediolateral plane showing signiﬁcan
MR jets medial to the clip are also shown. B shows a diastolic frame w
second clip deployment and shows no residual MR jet lateral to the se
white arrow heads) separated by a wider distance due to 2 clips in Dnimals (20) and humans (5). Although TEE can bhow the coronary sinus ostium and its diameter in the
roximal and mid- to distal course for stent sizing,
ssessment of coronary sinus length and its relation to
he mitral annulus and to the circumflex coronary
rtery remains difficult by TEE. TTE and TEE can
evertheless determine acute or chronic mitral annular
iameter reduction with coronary sinus stent place-
ent and its effect on MR severity.
CE during percutaneous MV repair. There is no pub-
ished human experience with ICE during percuta-
eous MV repair or aortic valve implantation. This
uthor’s experience with ICE in animal experiments
uggests that ICE can be an adjunctive if not a sole
maging modality during percutaneous valve inter-
entions (21) (Fig. 11, Online Video 8). ICE along
ith TEE may facilitate edge-to-edge MV repair
rocedure by visualizing intracardiac structures that
ay be difficult to delineate due to shadowing from
alcification or prosthetic material during TEE.
chocardiography in percutaneous aortic valve implan-
ation. Percutaneous aortic valve implantation is an
merging alternative for inoperable patients with
evere aortic stenosis and can be deployed using an
ntegrade (1) or retrograde (2,22) approach. Pres-
ntly, there are 2 catheter-based treatment systems
the Cribier-Edwards Aortic Bioprosthesis [2] and
he CoreValve ReValving System) utilizing either a
ent
sidual MR jet (white arrow) lateral to the Evalve clip in A. Two trivial
double oriﬁce mitral inﬂow (white arrowheads). C is obtained after
d clip, and D shows double mitral inﬂow with 2 oriﬁces (shown by
us 1 clip in B. Also see Online Videos 7A and 7B.loym
t re
ith a
conalloon-expandable or a self-expanding frame that
u
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1234nfolds a pericardial tissue valve within the dis-
laced diseased aortic valve. Current Edwards Sa-
ien series and CoreValves have CE mark approval
n Europe. Compared with surgical aortic valve
eplacements, percutaneous valve implantation
eads to lower mean gradients but increased inci-
ence of mild or moderate PV leak (23). TTE is
ssential for pre-procedure screening. Although the
rocedure can be performed under fluoroscopic
uidance alone, TEE can accurately measure aortic
alve annulus, LV outflow tract, and ascending
orta to assist in selection of prosthetic valve size. A
ifference of up to 4 mm between the TTE and the
EE annulus measurements can occur and may
ead to a change in valve size (24). TEE provides
ssessment of LV and valve function and thoracic
ortic anatomy. Severe, mobile plaque supports
tilization of the transapical approach, which avoids
anipulation of large catheters in the aorta. Three-
imensional TEE is particularly invaluable in eval-
ating aortic atheroma (Online Fig. E11).
During implantation, TEE evaluates the exact
A B
D E
Figure 11. Intracardiac Echocardiography During Percutaneous
Intracardiac views obtained by Acunav catheter in the right atrium
by the Brockenbrough needle. B shows J-shaped tip of guidewire in
leaﬂets of the MV with the ICE catheter advanced across the interat
short-axis view of the MV at the base with a central suture and clip
of suture and clip (Edwards Lifesciences, Irvine, California). The SAX
and pulmonic valves. E shows aortic root, left main coronary artery
advancing the ICE catheter tip into the right ventricle. Also see Onlosition of the deployment catheter and valve, Phich is critical for valve function. The 14- or
6-mm long Edwards prosthesis relies on traction
ith the native annulus for post-deployment stabil-
ty. Although the prosthesis must be positioned
istal enough to permanently stent open the native
ortic valve cusps, slightly more than one-half of the
rosthesis should remain on the LV side of the
ortic valve annulus. Deployment of the apparatus
t the level of the sinuses of Valsalva is too distal,
ay lead to aortic regurgitation, and risks valve
mbolization. Ascending aortic dilation is therefore
ot a contraindication for the Edwards valve since
he valve sits inside the native aortic annulus (25).
arly assessment of PV regurgitation is crucial.
ignificant transvalvular aortic regurgitation sug-
ests overexpansion of the prosthesis, which may
equire deployment of a second prosthetic valve
ithin the first. Following prosthetic valve deploy-
ent, TEE can immediately assess prosthetic valve
osition, in relation to the LV outflow tract and
ortic valve plane, prosthetic valve leaflet mobility,
alve area, and gradients and presence of central and
C
F
Therapy
swine. A shows tenting of the interatrial septum (white arrow)
LA after transseptal puncture. C shows anterior and posterior
septum into the LA and the transducer facing down. D shows a
ite arrow) and a double oriﬁce MV created after the deployment
was obtained by advancing the ICE catheter across the tricuspid
ite arrow), and LV, and F is a 4-chamber view obtained by
Video 8. Abbreviations as in Figures 1 and 2.MV
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(whV regurgitation. Multiple views are essential to
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1235etermine the site and degree of aortic regurgitation
ost-implant and the need for further balloon
ilation. Acoustic shadowing off the stent may
ake evaluation of PV leak difficult. The short-axis
iew most reliably distinguishes PV from transval-
ular aortic regurgitation. This distinction is diffi-
ult to make by fluoroscopy and aortic root contrast
njection. TEE greatly facilitates detection of pro-
edural complications such as presence of thrombi
n catheters, development of pericardial effusion,
ny interference of the procedure with MV mo-
ion, development of MR, possible compression
f coronary ostia by native aortic valve leaflets (by
howing new wall motion abnormalities), and
ortic hematoma or dissection during or after the
rocedure. Real-time 3D TEE may provide su-
erior spatial visualization of the cardiac struc-
ures and facilitate the detection of procedure-
elated complications that might improve patient
Figure 12. Intracardiac Echocardiography During Percutaneous
ICE imaging during percutaneous aortic valve (Edwards Lifesciences
the right atrium. Wire across the aortic valve (white arrow) placed
aortic valve and into the LV outﬂow tract in B, balloon expansion o
deployment with a space between the stent post and the posterior
balloon inﬂation for stent expansion in F. Also see Online Videos 9Autcome (26). It may be helpful in evaluating doronary ostia in relation to the stented valve
Online Fig. E12).
ntracardiac echocardiography in percutaneous aortic
alve implantation. This author has used ICE as an
maging guide in swine during the development of a
ercutaneous aortic valve (27). ICE allowed accurate
easurement of aortic annulus, assisted with place-
ent of the device within the aortic annulus, helped in
ssessment of PV leak post-valve deployment and the
eed for further balloon expansion, and in assessment
f post-deployment gradients (Fig. 12, Online Videos
A, 9B, and 9C).
chocardiography in pulmonic valve implantation.
urrently available percutaneous pulmonic valve is
balloon-expandable valve stent composed of a
ovine jugular valve mounted in a platinum/iridium
tent (Medtronic Corp./NuMED Inc., Medtronic
nc., Minneapolis, Minnesota) and is largely im-
lanted in children with complex congenital heart
Therapy
lacement obtained in a pig with the ICE catheter tip placed in
retrograde approach in A, delivery sheath advanced across the
e stent at the level of the aortic valve in C, incomplete stent
tic root (white asterisk) and ﬂow through this space in D, further
, and 9C. Ao  aortic root.AV
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1236rtery valved conduits with conduit valve stenosis
nd/or regurgitation (28). The major drawback in
ulmonary valve replacement is limitation in bovine
ugular venous valve size, which rarely exceeds 18 to
2 mm in diameter. Echocardiography plays a
iagnostic role pre-procedure and post-procedure
o evaluate implanted pulmonic valve function.
luoroscopy and cineangiography remain key im-
ging modalities during valve deployment. ICE has
een used in isolated case reports and provides
dequate anatomic and physiologic information to
uide percutaneous pulmonic valve placement (29).
onclusions
ecent studies have shown successful percutaneous
V repair by edge-to-edge procedure and stent-
ounted aortic and pulmonic valve implantation.
he real-time guidance of this procedure requires a
nique and intense collaboration between echocar-
iologist and interventionalist not hitherto seen in
ther catheterization lab procedures or intraopera-
ive TEE (30). This collaboration includes use of
ommon vocabulary, training of the interventional-
st on basic echocardiographic views critical for the
rocedure, and possession of unique interventional
maging skill by the echocardiologist. Besides con-
entional diagnostic echocardiography, hybrid
iews showing endovascular devices and their rela-
ionship to cardiac structures and command on 3D
econstruction of cardiac anatomy from 2D images
s required. Limitations of 2D TEE imaging in-
lude shadowing from devices, loss of imaging
lane from respiratory motion in an intubatedstented valve without use of cardiopul- ogy: a position she procedure due to stomach air, poor contact of
robe with the stomach wall due to secretions, and
eduction in heart size from blood loss. Further
evelopments in delivery technology, valve design
mprovements, and availability of follow-up data
ill lead to proliferation of percutaneous valve
echnology and in turn development of interven-
ionists dedicated to treatment of structural heart
isease and echocardiologists dedicated to interven-
ional echocardiography.
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A P P E N D I X
or an overview of the echocardiographic im-
ging modalities, accompanying Figures E1 to
12, and accompanying Videos 1A to 9C with
heir legends, please see the online version of
his paper.
